ResearcherMichael E. DeBakey VA Medical CenterActive in the last 2 years
Yan Liu
Matched on ORCID iD 0000-0002-9123-4974; OpenAlex author ID A5100351125. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 7
- The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System. Co-author DOI 10.1097/mpa.0000000000002272↗
- Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Co-author DOI 10.1007/s10620-023-08035-8↗
- A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients. Co-author DOI 10.3892/or.2019.6979↗
- Immunomagnetic Lipid Separation and Plastin Identification for Pancreatic Cancer Cells and Its Clinical Application. Co-author DOI 10.1166/jbn.2018.2535↗
- A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Co-author DOI 10.1053/j.gastro.2013.08.018↗
- Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. Co-author DOI 10.1186/1756-8722-5-15↗
- Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. Co-author DOI 10.1186/1756-9966-30-35↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hashem B. El‐Serag · 2 shared papers, 2023–2024 · strength 0.43
- Fasiha Kanwal · 2 shared papers, 2023–2024 · strength 0.43
- Hardeep Singh · 2 shared papers, 2023–2024 · strength 0.43
- Natalia I. Khalaf · 2 shared papers, 2023–2024 · strength 0.43
- Yan Sun · 1 shared paper, 2019 · strength 0.12
- Xianjun Sun · 1 shared paper, 2018 · strength 0.09
- Tinghui Jiang · 1 shared paper, 2018 · strength 0.09
- Huamin Wang · 2 shared papers, 2012–2013 · strength 0.07
- Paper A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. DOI 10.1053/j.gastro.2013.08.018↗
- Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
- Baoan Ji · 2 shared papers, 2012–2013 · strength 0.07
- Paper A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. DOI 10.1053/j.gastro.2013.08.018↗
- Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
- Craig D. Logsdon · 2 shared papers, 2012–2013 · strength 0.07
- Paper A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. DOI 10.1053/j.gastro.2013.08.018↗
- Paper Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. DOI 10.1186/1756-8722-5-15↗
- Bincy Philip · 1 shared paper, 2013 · strength 0.03
- Jarosław Daniluk · 1 shared paper, 2013 · strength 0.03
- Deyali Chatterjee · 1 shared paper, 2013 · strength 0.03
- Christina Lynn Roland · 1 shared paper, 2013 · strength 0.03
- Zobeida Cruz‐Monserrate · 1 shared paper, 2013 · strength 0.03
- Jason B. Fleming · 1 shared paper, 2013 · strength 0.03
- Haojie Huang · 1 shared paper, 2013 · strength 0.03
- David Z. Chang · 1 shared paper, 2012 · strength 0.03
- James L. Abbruzzese · 1 shared paper, 2012 · strength 0.03
- Patrick Hwu · 1 shared paper, 2012 · strength 0.03
- Ying Ma · 1 shared paper, 2012 · strength 0.03
- Zheng Lu · 1 shared paper, 2011 · strength 0.02
- Hongyu Wu · 1 shared paper, 2011 · strength 0.02
- Luo‐Wei Wang · 1 shared paper, 2011 · strength 0.02
- Jianxia Ma · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.